Profiel
Alexis Denis worked as a Director of Medicinal Chemistry at Mutabilis SA from 2009 to 2011.
Later, from 2016 to 2020, he worked as a Director of Discovery Division at Oncodesign SA. Prior to his work experience, he earned a doctorate degree from Université Pierre et Marie Curie.
Eerdere bekende functies van Alexis Denis
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCODESIGN | Corporate Officer/Principal | 01-07-2020 |
Mutabilis SA
 Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Chief Tech/Sci/R&D Officer | 24-12-2009 |
Opleiding van Alexis Denis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Mutabilis SA
Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Oncodesign SA is a biopharmaceutical company, which engages in the provision of solutions for the assessment and validation of anti-cancer therapies. It also offers services in pharmacology, pharmco-imaging, bio-analysis, bio-banking, translational bio-makers, and bio-decontamination. The firm operates through the following business units: Service, Biotech, and Artificial Intelligence. The company was founded by Philippe Genne and Eric Solary on January 17, 1995 and is headquartered in Dijon, France. | Health Technology |
